Techanivate Anchalee, Kiatgungwanglia Predee, Yingsakmongkol Wicharn
Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
J Med Assoc Thai. 2003 Mar;86(3):262-9.
Intrathecal administration of preservative free morphine (spinal morphine) provides excellent post-operative analgesia. Since the dura is readily accessible by the surgeon during lumbar spinal surgery, it would be convenient and attractive to administer morphine into the spinal space to provide adequate post-operative analgesia in these patients.
A prospective randomized controlled study evaluated the post-operative analgesic effect of spinal morphine after lumbar laminectomy with fusion. Forty patients were randomly allocated to two groups, morphine (MO) or normal saline (NSS). Morphine 0.3 mg in normal saline 0.3 ml or normal saline 0.3 ml was injected into the dural sac under direct visualization before closing the wound. An intravenous PCA morphine device was provided for post-operative pain relief.
Median visual analog scale (VAS) pain scores were lower in the MO group at 2, 4, 24 and 48 h after surgery (1, 1, 2.75 and 1.5 cm in the MO group vs 4.25, 4.25, 5 and 4 cm in the NSS group) (p < 0.05). The time to first patient control analgesia (PCA) demand was delayed in the MO group (131.7 min vs 29.6 min) (p < 0.05). The cumulative doses of PCA morphine consumption were lower in the MO group in the first 24 h and 24-48 h (13.7 and 15.9 mg vs 41.3 mg and 27.1 mg) (p < 0.001). The incidence of pruritus was higher in the MO group in 24 h and 24-48 h (45%, and 45% vs 5% and 10%) (p < 0.05). The incidence and severity of nausea, vomiting and sedation were not different. No patient developed respiratory depression or postdural puncture headache (PDPH). The patients' satisfaction with post-operative pain management was 100 per cent in the MO group and 85 per cent in the NSS group.
Spinal morphine improved post-operative pain relief after lumbar laminectomy.
鞘内注射无防腐剂吗啡(脊髓吗啡)可提供出色的术后镇痛效果。由于在腰椎手术中外科医生可轻易触及硬脊膜,因此在这些患者的脊髓间隙注射吗啡以提供充分的术后镇痛既方便又有吸引力。
一项前瞻性随机对照研究评估了腰椎椎板切除融合术后脊髓吗啡的术后镇痛效果。40例患者被随机分为两组,吗啡组(MO)或生理盐水组(NSS)。在伤口缝合前,在直视下将0.3mg吗啡溶于0.3ml生理盐水中或0.3ml生理盐水注入硬脊膜囊。术后提供静脉自控镇痛(PCA)吗啡装置用于缓解疼痛。
术后2、4、24和48小时,MO组的视觉模拟量表(VAS)疼痛评分中位数较低(MO组分别为1、1、2.75和1.5cm,NSS组分别为4.25、4.25、5和4cm)(p<0.05)。MO组首次患者自控镇痛(PCA)需求时间延迟(131.7分钟对29.6分钟)(p<0.05)。前24小时和24至48小时内,MO组PCA吗啡累计消耗量较低(13.7mg和15.9mg对41.3mg和27.1mg)(p<0.001)。24小时和24至48小时内,MO组瘙痒发生率较高(分别为45%和45%,NSS组为5%和10%)(p<0.05)。恶心、呕吐和镇静的发生率及严重程度无差异。无患者出现呼吸抑制或硬膜穿刺后头痛(PDPH)。MO组患者对术后疼痛管理的满意度为100%,NSS组为85%。
脊髓吗啡改善了腰椎椎板切除术后的疼痛缓解。